Saturday, May 21, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Argentine media highlight advances in Cuban vaccines

Argentine media highlight advances in Cuban vaccines

Buenos Aires, Jul 9 (Prensa Latina) Argentine media today highlighted the authorization of the emergency use of the Cuban vaccine against Covid19 Abdala, the first developed in Latin America to be approved.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

Newspaper Página 12 reviewed in a note the good news arrival from the Caribbean island, which announced this Friday that after a rigorous process of evaluation of the file and having carried out the inspections of the plants involved, the emergency use of the drug Abdala was authorized.

That media said Cuba hopes to have 70 percent of its population vaccinated in August and 100 percent before the end of the year and would become the first country in the world to immunize its entire population with its own vaccines.

For its part, local Telam news agency also echoed Abdala’s authorization, whose effectiveness is 92.28 percent according to local studies, it is already being administered to Cubans and was exported to Venezuela where it will also be produced. The report also added that several nations in the region showed interest in acquiring it, including Argentina.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.